arrow
G

Giulia Orsi

vita-salute san raffaele university
H指数:18
被引数:1,094

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Impact of center-level protocol adherence on neoadjuvant treatment outcome in pancreatic ductal adenocarcinoma

中心级方案依从性对胰腺导管腺癌新辅助治疗结局的影响

2026-09-010
PRE
Short-term versus long-course neoadjuvant chemotherapy for resectable and borderline resectable pancreatic ductal adenocarcinoma (PACT-21 CASSANDRA): results from the second randomisation analysis of a randomised, open-label, 2 × 2 factorial phase 3 trial

可切除和临界可切除胰腺导管腺癌的短期与长期新辅助化疗比较(PACT-21 CASSANDRA):一项随机、开放标签、2×2析因设计的III期试验第二次随机化分析结果

2026-09-010
OAAI
Results of a randomized phase III trial of pre-operative chemotherapy with mFOLFIRINOX or PAXG regimen for stage I-III pancreatic ductal adenocarcinoma

一项关于术前化疗联合mFOLFIRINOX或PAXG方案治疗I-III期胰腺导管腺癌的随机III期试验结果

2025-10-310
PRE
Long-term Outcomes of EUS-guided Gastroenterostomy (LONG-RANGE study): a prospective cohort study tracking symptoms recurrence, reintervention timelines and stent changes over time

EUS引导下胃空肠吻合术的长期结局(LONG-RANGE研究):一项前瞻性队列研究,追踪症状复发、再干预时间线及支架更换情况随时间的变化

2025-10-310
PRE
Diagnostic delay at diagnosis and time-to-treatment influence overall survival of pancreatic cancer patients

诊断延迟和从诊断到治疗的时间影响胰腺癌患者的总生存期

2025-04-020
PRE
Survival analysis of the non-metastatic cohort of the Italian Association for Medical Oncology (AIOM) Guideline Application in Real world: multi- Institutional Based survey of Adjuvant and fi rst-Line pancreatic Ductal adenocarcinoma treatment in Italy (GARIBALDI)
2025-01-010
OAAI
Survival analysis of the metastatic cohort of Italian Association of Medical Oncology (AIOM) GARIBALDI survey

意大利医学肿瘤学会(AIOM)加里波第调查中转移性队列的生存分析

2024-11-010
OAAI
Germline pathogenic variants of cancer predisposition genes in a multicentre Italian cohort of pancreatic cancer patients.

意大利多中心胰腺癌患者癌症易感性基因的种系致病变异。

2024-09-010
PRE
Isolated LUng Metastases in pancreatic AdenoCArcinoma patients in a multicenter Italian cohort: The LUMACA study

孤立性肺转移瘤在胰腺腺癌患者中的多中心意大利队列研究:LUMACA研究

2024-09-010
PRE
Non-metastatic cohort of the Italian Association for Medical Oncology (AIOM) guideline application in real-world: MultiInstitutional based survey of adjuvant and first-line pancreatic ductal adenocarcinoma treatment in Italy (GARIBALDI)
2023-10-010
OA
Italian Association for Medical Oncology (AIOM) guideline application in real-world: Multi-institutional based survey of adjuvant and first-line pancreatic ductal adenocarcinoma treatment in Italy (GARIBALDI) - survival analyses in the metastatic cohort
2023-10-010
PRE
Routine Molecular Profiling in Both Resectable and Unresectable Pancreatic Adenocarcinoma: Relevance of Cytologic Samples
2023-10-019
PRE
EUS-guided gastroenterostomy for management of malignant gastric outlet obstruction: a prospective cohort study with matched comparison with enteral stenting

EUS引导下胃肠吻合术治疗恶性胃出口梗阻: 一项前瞻性队列研究,并与肠内支架置入术进行比较

2023-09-0125
OAAI